Loading: 100%
TACTILE SYSTEMS TECHNOLOGY INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 335 (as per Q2 2017)no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker TCMDno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Preferred Shares, OfStockAxis_tcmd_ConvertiblePreferredStockaNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17010203040
datesClosing price (adj.)
13.10.201731.92
11.10.201730.99
04.10.201732.75
27.09.201728.95
20.09.201733.57
13.09.201734.67
06.09.201733.87
30.08.201732.24
23.08.201733.90
16.08.201733.27
09.08.201732.97
02.08.201728.49
26.07.201730.29
19.07.201730.52
12.07.201730.01
05.07.201727.52
27.06.201728.20
20.06.201726.99
13.06.201725.02
06.06.201725.22
30.05.201723.31
23.05.201723.80
16.05.201723.14
09.05.201721.68
02.05.201718.90
25.04.201719.02
18.04.201717.11
11.04.201717.95
04.04.201718.15
28.03.201718.00
21.03.201718.86
14.03.201718.56
07.03.201719.56
28.02.201720.23
21.02.201716.50
14.02.201715.48
07.02.201716.00
31.01.201715.41
24.01.201716.10
17.01.201715.17
10.01.201715.50
03.01.201715.70
27.12.201616.20
19.12.201616.07
12.12.201615.31
05.12.201614.90
28.11.201616.23
21.11.201618.34
14.11.201617.35
07.11.201617.57
31.10.201617.77
24.10.201619.33
17.10.201619.12
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per , in USD
n/a
Market Capitalisation
in million USD
0n/a
Enterprise Value
in million USD
0n/a
Common Shares Outstanding
as per Jun 30, 2017
17,541,371n/a
Preferred Shares Outstanding
as per Jun 30, 2017
17,526,171n/a
Average Basic Shares Outstanding
TTM
15,752,224n/a
Average Diluted Shares Outstanding
TTM
18,080,481n/a
Index Membership
n/a
Business Summary
Tactile Systems Technology Inc is a medical technology company. The Company develops and provides medical devices for the treatment of chronic swelling condition at home. Its products include Flexitouch System, the Entre System, and the ACTitouch System.
no data available
Key Financials & Ratios (all figures TTM as per Jun 30, 2017, million USD, full statements further below)
Profit & Loss
Revenues 97n/a
Gross Profit 71n/a
Operating Income 2n/a
EBITDA 3n/a
Net Profit 5n/a
Balance Sheet
Cash and Cash Equivalents 39n/a
Receivables 13n/a
Total Current Assets 67n/a
PP&E 3n/a
Total Assets 78n/a
Accounts Payable 7n/a
Current Debt 0n/a
Total Current Liabilities 11n/a
Long-Term Debt 0n/a
Total Liabilities 12n/a
Total Equity 66n/a
Cash Flow
Depreciation & Amortisation 1n/a
Change in Working Capital -6n/a
Operating Cash Flow 3n/a
Net Change in PP&E and Intangibles -2n/a
Investing Cash Flow -23n/a
Dividends Paid -8n/a
Financing Cash Flow 31n/a
Total Change in Cash 11n/a
Free Cash Flow -2n/a
Profitability Ratios
Gross Margin 72.8%n/a
Operating Margin 2.1%n/a
Net Profit Margin 5.3%n/a
Return on Equity 7.8%n/a
Return on Assets 6.6%n/a
Per Share Figures
Basic EPS 0.33n/a
Diluted EPS 0.29n/a
Sales per Share 6.17n/a
Book Value per Share 4.20n/a
FCF per Share -0.13n/a
Dividends per Share 0.52n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value n/a
Other Ratios
Current Ratio 602.2%n/a
Liabilities to Equity Ratio 17.7%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '14FY '15FY '16
Revenue
48
63
85
Sales & Services Revenue
0
0
0
Financing Revenue
0
0
0
Other Revenue
0
0
0
Cost of revenue
-13
-17
-23
Cost of Goods & Services
0
0
0
Cost of Financing Revenue
0
0
0
Cost of Other Revenue
0
0
0
Gross Profit
35
46
62
Other Operating Income
0
0
0
Operating Expenses
-31
-43
-57
Selling, General & Administrative
-28
-38
-53
Selling & Marketing
0
0
0
General & Administrative
0
0
0
Research & Development
-3
-4
-4
Depreciation & Amortization
0
0
0
Provision For Doubtful Accounts
0
0
0
Other Operating Expense
0
0
0
Operating Income (Loss)
4
3
4
Non-Operating Income (Loss)
0
0
0
Interest Expense, net
0
0
0
Interest Expense
0
0
0
Interest Income
0
0
0
Other Investment Income (Loss)
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
Income (Loss) from Affiliates
0
0
0
Other Non-Operating Income (Loss)
0
0
0
Pretax Income (Loss), Adjusted
4
3
4
Abnormal Gains (Losses)
0
0
0
Acquired In-Process R&D
0
0
0
Merger / Acquisition Expense
0
0
0
Abnormal Derivatives
0
0
0
Disposal of Assets
0
0
0
Early extinguishment of Debt
0
0
0
Asset Write-Down
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
Sale of Business
0
0
0
Legal Settlement
0
0
0
Restructuring Charges
0
0
0
Sale of and Unrealized Investments
0
0
0
Insurance Settlement
0
0
0
Other Abnormal Items
0
0
0
Pretax Income (Loss)
4
3
4
Income Tax (Expense) Benefit, net
-2
-2
-1
Current Income Tax
0
0
0
Deferred Income Tax
0
0
0
Tax Allowance/Credit
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
Income (Loss) from Continuing Operations
2
1
3
Net Extraordinary Gains (Losses)
0
0
0
Discontinued Operations
0
0
0
XO & Accounting Charges & Other
0
0
0
Income (Loss) Including Minority Interest
2
1
3
Minority Interest
0
0
0
Net Income
2
1
3
Preferred Dividends
-2
-2
-1
Other Adjustments
0
0
0
Net Income Available to Common Shareholders
0
0
2
Remarks
restated on Feb 27, 2017 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
7
42
Cash & Cash Equivalents
n/a
7
31
Short Term Investments
n/a
0
11
Accounts & Notes Receivable
n/a
14
15
Accounts Receivable, Net
n/a
14
15
Notes Receivable, Net
n/a
0
0
Unbilled Revenues
n/a
0
0
Inventories
n/a
6
7
Raw Materials
n/a
0
0
Work In Process
n/a
0
0
Finished Goods
n/a
0
0
Other Inventory
n/a
0
0
Other Short Term Assets
n/a
2
1
Prepaid Expenses
n/a
1
1
Derivative & Hedging Assets
n/a
0
0
Assets Held-for-Sale
n/a
0
0
Deferred Tax Assets
n/a
2
0
Income Taxes Receivable
n/a
0
0
Discontinued Operations
n/a
0
0
Miscellaneous Short Term Assets
n/a
0
0
Total Current Assets
n/a
29
64
Property, Plant & Equipment, Net
n/a
1
2
Property, Plant & Equipment
n/a
0
0
Accumulated Depreciation
n/a
0
0
Long Term Investments & Receivables
n/a
0
0
Long Term Investments
n/a
0
0
Long Term Marketable Securities
n/a
0
0
Long Term Receivables
n/a
0
0
Other Long Term Assets
n/a
6
8
Intangible Assets
n/a
0
0
Goodwill
n/a
0
0
Other Intangible Assets
n/a
0
0
Prepaid Expense
n/a
0
0
Deferred Tax Assets
n/a
0
3
Derivative & Hedging Assets
n/a
0
0
Prepaid Pension Costs
n/a
0
0
Discontinued Operations
n/a
0
0
Investments in Affiliates
n/a
0
0
Miscellaneous Long Term Assets
n/a
6
5
Total Noncurrent Assets
n/a
8
10
Total Assets
n/a
37
74
Liabilities and owners' equity
Payables & Accruals
n/a
9 8511000
14 13726000
Accounts Payable
n/a
3 3336000
5 5018000
Accrued Taxes
n/a
1 904000
1 823000
Interest & Dividends Payable
n/a
0 0
0 0
Other Payables & Accruals
n/a
4 4271000
8 7885000
Short Term Debt
n/a
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
Other Short Term Liabilities
n/a
1 991000
0 67000
Deferred Revenue
n/a
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
1 991000
0 67000
Total Current Liabilities
n/a
10 9502000
14 13793000
Long Term Debt
n/a
0 0
0 0
Long Term Borrowings
n/a
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
Other Long Term Liabilities
n/a
0 193000
1 503000
Accrued Liabilities
n/a
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
Pensions
n/a
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
Deferred Compensation
n/a
0 193000
0 0
Deferred Revenue
n/a
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 0
1 503000
Total Noncurrent Liabilities
n/a
0 193000
1 503000
Total Liabilities
n/a
10 9695000
14 14296000
Preferred Equity
n/a
33 32927000
0 0
Share Capital & Additional Paid-In Capital
n/a
0 3000
62 62423000
Common Stock
n/a
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
Other Share Capital
n/a
0 0
0 0
Treasury Stock
n/a
0 0
0 0
Retained Earnings
n/a
-6 -5652000
-3 -2773000
Other Equity
n/a
0 0
0 -11000
Equity Before Minority Interest
n/a
27 27278000
60 59639000
Minority Interest
n/a
0 0
0 0
Total Equity
n/a
27 27278000
60 59639000
Total Liabilities & Equity
n/a
37 36973000
74 73935000
Remarks restated on n/a restated on Feb 27, 2017 n/a restated on Aug 7, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '14FY '15FY '16
Net Income/Starting Line
2
1
3
Net Income
0
0
0
Net Income From Discontinued Operations
0
0
0
Other Adjustments
0
0
0
Depreciation & Amortization
1
1
1
Non-Cash Items
2
1
2
Stock-Based Compensation
0
0
0
Deferred Income Taxes
0
0
0
Other Non-Cash Adjustments
0
0
0
Change in Working Capital
-6
-1
2
(Increase) Decrease in Accounts Receivable
0
0
0
(Increase) Decrease in Inventories
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
Increase (Decrease) in Other
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
Cash from Operating Activities
-1
2
7
Change in Fixed Assets & Intangibles
0
-1
-1
Disposition of Fixed Assets & Intangibles
0
0
0
Disposition of Fixed Assets
0
0
0
Disposition of Intangible Assets
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
Purchase of Fixed Assets
0
0
0
Acquisition of Intangible Assets
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
Net Change in Long Term Investment
0
0
-11
Decrease in Long Term Investment
0
0
0
Increase in Long Term Investment
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
Net Cash from Divestitures
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
Cash for Joint Ventures
0
0
0
Net Cash from Other Acquisitions
0
0
0
Other Investing Activities
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
Cash from Investing Activities
0
-1
-12
Dividends Paid
0
0
-8
Cash From (Repayment of) Debt
0
-1
-5
Cash From (Repayment of) Short Term Debt, net
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
Repayments of Long Term Debt
0
0
0
Cash From Long Term Debt
0
0
0
Cash From (Repurchase of) Equity
0
1
41
Increase in Capital Stock
0
1
41
Decrease in Capital Stock
0
0
0
Other Financing Activities
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
Cash from Financing Activities
0
0
28
Net Cash Before Disc. Operations and FX
-1
2
24
Change in Cash from Disc. Operations and Other
0
0
0
Net Cash Before FX
-1
2
24
Effect of Foreign Exchange Rates
0
0
0
Net Changes in Cash
-1
2
24
Remarks
restated on Feb 27, 2017 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
restated on Feb 27, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo